Stock ScreenerStock IdeasBiotech Breakthroughs
Best Biotech Stocks To Buy Now
Top biotech stocks that analysts expect to be profitable within the next 3 years

Industry: Biotechnology
Forecast Earnings Growth: Positive
Ticker
Company
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
CORT
CORCEPT THERAPEUTICS INC
$12.56BN/A0.00%N/AN/AN/AN/A
ARQT
ARCUTIS BIOTHERAPEUTICS INC
$3.16BN/A0.00%N/AN/AN/AN/A
ALNY
ALNYLAM PHARMACEUTICALS INC
$29.40BN/A0.00%N/AN/AN/AN/A
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLC
$5.91BN/A0.00%N/AN/AN/AN/A
VCEL
VERICEL CORP
$2.06BN/A0.00%N/AN/AN/AN/A
RPRX
ROYALTY PHARMA PLC
$32.87B1.62%48.40%$0.2350$0.9333%0
KRYS
KRYSTAL BIOTECH INC
$9.54BN/A0.00%N/AN/AN/AN/A
HALO
HALOZYME THERAPEUTICS INC
$12.47BN/A0.00%N/AN/AN/AN/A
ZVRA
ZEVRA THERAPEUTICS INC
$593.24MN/A0.00%N/AN/AN/AN/A
TGTX
TG THERAPEUTICS INC
$8.31BN/A0.00%N/AN/AN/AN/A
BMRN
BIOMARIN PHARMACEUTICAL INC
$11.07BN/A0.00%N/AN/AN/AN/A
JAZZ
JAZZ PHARMACEUTICALS PLC
$15.30BN/A0.00%N/AN/AN/AN/A
MDXG
MIMEDX GROUP INC
$669.04MN/A0.00%N/AN/AN/AN/A
EXEL
EXELIXIS INC
$14.47BN/A0.00%N/AN/AN/AN/A
ADMA
ADMA BIOLOGICS INC
$2.18BN/A0.00%N/AN/AN/AN/A
LGND
LIGAND PHARMACEUTICALS INC
$6.04BN/A0.00%N/AN/AN/AN/A
VRTX
VERTEX PHARMACEUTICALS INC
$127.93BN/A0.00%N/AN/AN/AN/A
UTHR
UNITED THERAPEUTICS CORP
$23.23BN/A0.00%N/AN/AN/AN/A
TECH
BIO-TECHNE CORP
$11.35B0.55%34.20%$0.0800$0.409%1
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
$2.31BN/A0.00%N/AN/AN/AN/A
REGN
REGENERON PHARMACEUTICALS INC
$75.69B0.50%8.70%$0.9400$3.708%0
VCYT
VERACYTE INC
$3.68BN/A0.00%N/AN/AN/AN/A
SPRO
SPERO THERAPEUTICS INC
$69.30MN/A0.00%N/AN/AN/AN/A
INCY
INCYTE CORP
$23.37BN/A0.00%N/AN/AN/AN/A
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.